Project Chintan

Transport and Pharma Lead Surge as Private Sector Dominates India's R&D Spending

India's corporate research and development spending has overtaken government contributions for the first time, fueled by massive investments from the transport and biotech sectors. New data indicates national R&D expenditure reached 0.83% of GDP and is projected to hit 0.9% by 2026.

· 2 min read

Key takeaways

  • Private sector R&D spending in India reached 51.8% of the national total in 2023-24, surpassing government expenditure for the first time.
  • The transportation industry is India's largest R&D investor, spending ₹39,137 crore in 2023-24, nearly tripling its 2018-19 levels.
  • India's R&D-to-GDP ratio rose to 0.83% in 2021-22 and is estimated to reach 0.9% by the 2025-26 period.
  • Biotechnology firms recorded the highest research intensity, allocating 16.8% of their total sales turnover to R&D initiatives.
  • The private sector has overtaken government institutions as the primary employer of full-time research and technical personnel.
Transport and Pharma Lead Surge as Private Sector Dominates India's R&D Spending

Corporate Investment Overtakes Public Funding

Data from the Department of Science and Technology (DST) Research and Development Statistics 2025-26 reveals a fundamental shift in how India finances innovation. For the first time, private industry contributions have eclipsed the combined spending of all government levels. Business enterprises accounted for 51.8% of national R&D expenditure in 2023-24, rising from 45.5% in 2021-22. This surge helped push the national R&D-to-GDP ratio to 0.83% in 2021-22, marking the first time since 2009-10 that the figure has exceeded the 0.8% mark. Projections suggest this intensity will reach 0.9% by 2025-26.

Sectoral Leaders in Research Spending

The transportation industry has emerged as the primary driver of this growth, investing ₹39,137 crore in 2023-24. This represents nearly a three-fold increase from the ₹14,000 crore recorded in 2018-19. Other major contributors include:

  • Drugs and Pharmaceuticals: ₹25,847 crore
  • Biotechnology: ₹10,321 crore
  • Information Technology: ₹9,587 crore
  • Electrical and Electronics: ₹6,779 crore

While transport leads in absolute volume, biotechnology displays the highest research intensity, dedicating 16.8% of its sales turnover to R&D activities. The total private sector expenditure of ₹1.27 lakh crore in 2023-24 was heavily concentrated; approximately 500 companies were responsible for 90% of the total investment, despite nearly 8,000 firms appearing in the DST database.

Workforce Migration to the Private Sector

The structural transformation extends to the labor market. Private industry now employs more full-time equivalent (FTE) researchers and technical staff than government agencies, central organizations, and state institutions combined. This reverses the trend seen in the 2020 DST report, where public sector entities were the dominant employers of the nation's scientific workforce. The vast majority of this private spending—₹1.11 lakh crore out of ₹1.27 lakh crore—originated from business enterprises, rather than private universities or independent research organizations.

Drivers of the Spending Spike

Official sources attribute the aggressive increase in corporate R&D to a post-pandemic shift in strategy, where companies recognized that long-term viability depended on innovation. Furthermore, analysts suggest that stricter Reserve Bank of India mandates regarding the transparent disclosure of R&D expenses have contributed to more accurate reporting. The DST maintained consistent data collection methods via self-reported questionnaires to ensure longitudinal accuracy between the 2020 and 2026 reporting cycles.

Source: The Hindu — Economy

Related stories